4-Chromenonyl-1,4-dihydropyridines and their use

Details 4-Chromenonyl-1,4-dihydropyridines and their use 4-Chromenonyl-1,4-dihydropyridines and their use

2011-08-02

2011-08-02

Andres, Janet L (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07989633

ABSTRACT:
The present application relates to novel 4-chromenonyl-1,4-dihydropyridines, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.

REFERENCES:
patent: 3775422 (1973-11-01), Bossert et al.
patent: 3862161 (1975-01-01), Bossert et al.
patent: 3966948 (1976-06-01), Bossert et al.
patent: 4540789 (1985-09-01), Goldmann et al.
patent: 4555512 (1985-11-01), Goldmann et al.
patent: 4628107 (1986-12-01), Goldmann et al.
patent: 2003146 (1971-07-01), None
patent: 3311003 (1984-09-01), None
patent: 3311005 (1984-09-01), None
patent: 0223744 (1987-05-01), None
R. E. Booth et al.: “Aldosterone,” Advances in Physiology Education, vol. 26, No. 1, Mar. 2002, pp. 8-20.
B. Pitt et al.: “Eplerenone, A Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction,” The New England Journal of Medicine, vol. 348, No. 14, Apr. 3, 2003, pp. 1309-1321.
B. Pitt et al.: “The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure,” The New England Journal of Medicine, vol. 341, No. 10, pp. 709-717, 1999.
H. A. Kuhn et al.: Innere Medizin—Ein Lehrbuch fur Studierende der Medizin and Arzte Bergrundet von Ludwig Heilmeyer, Springer-Verlag, Berlin, Heidelberg, New York, 1982.
M. A. Zaman et al.; “Drugs Targeting the Renin-Angiotension-Aldosterone System,” Nature Reviews Drug Discovery, vol. 1, Aug. 2002, pp. 621-636.
N. M. Kaplan: “The Current Epidemic of Primary Aldosteronism: Causes and Consequences,” Journal of Hypertension, 2004, vol. 22, pp. 863-869.
A. Chiarini et al.: “Negative Inotropic and Chronotropic Activity of Calcium Channel Ligands Possessing a Xanthone 1,4-Dihydropyridine Backbone,” Forsch Drug Research, vol. 42, No. 6, 1992, pp. 797-801.
D. M. Stout et al.: “Recent Advances in the Chemistry of Dihydropyridines,” Chem. Rev., vol. 82, 1982, pp. 223-243.
H. Meyer et al.: “Dihydropyridniie, II—Synthese von 1,4-Dihydropyridinen mit Bruckenkppf-N-Atom,” Liebigs Ann. Chem., 1977, pp. 1888-1894.
H. Meyer et al.: “Synthese von 2-Aminodihydropyridinen durch Michael-Addition,” Liebigs Ann. Chem., 1977, pp. 1985-1908.
H. Meyer et al.: :Synthese von 6-Alkoxy-2-Amino-4,5-Dihydropyridin-3,5-Dicarbon-Saureestern, Liebigs Ann. Chem., 1976, pp. 1762-1766.
R. J. Gould et al.: “[3H]Nitrendipine-Labeled Calcium Channels Discriminate Inorganic Calcium Agonists and Antagonists,” Proc. Natl. Acad. Sci., vol. 79, Jun. 1982, pp. 3656-3660.
P. Babin: “Nouveau Mode de Cyclisation de Ceto-Ylures. Application a une Synthese Originale D'Acy1-3-Hydroxy-4-Coumarines et de L'Hydroxy-11 Benzo-(b) 12[H] Xanthone-12,” Tetradedrno, vol. 37, 1981, pp. 1131-1139.
R. J. Chambers et al.: “Development of 2,2-Dimethylchromanol Cysteinyl LT1Receptor Antagonists,” Bioorganic & Medicinal Chemistry Letters, vol. 8, 1998, pp. 3577-3582.
D. Alker et al.: “Long-Acating Digydropyridine Calcium Antagonists. 9. Structure Activity Relationships around Amlodipine,” Eur. J. Med. Chem., vol. 26, 1991, pp. 907-913.
F. J. Ehlert et al.: “The Binding of [3H]Nitrendifine to Receptors for Calcium Channel Antagonists in the Heart, Cerebral Cortex, and Ileum of Rats,” Life Sciences, vol. 30, 1982, pp. 2191-2202.
J. I. Ubeda et al.: Synthesis of 6-Formyl Derivatives of 5,8-Dimethoxycarbostyryl,: Heterocycles, vol. 38, No. 12, 1994, pp. 2677-2689.
H. J. Bestmann et al.: “Chromones from Acylsalicylic Acids,” Chemistry Letters, 1983, pp. 997-998.
C. Kashima et al.: “The Alkylation of 3,5-Dimethylisoxazole,” Bulletin of the Chemical Society of Japan, vol. 46, No. 1, 1973, pp. 310-313.
S. G. Jagadeesh et al.: “Synthesis of 3-Methylchromone-8-Acetic Acids and 2-Methyl-Chromone-8-Carboxylic Acids,” Synthetic Communications, vol. 31, No. 10, 2001, pp. 1547-1557.
Budriesi, et al., 1,4-Dihydropyridine derivatives as calcium channel modulators: the role of 3-methoxy-flavone moiety, Bioorg. Med. Chem., 13(10): 3423-3430 (2005).

Affiliated with

Also associated with

Rating

4-Chromenonyl-1,4-dihydropyridines and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-Chromenonyl-1,4-dihydropyridines and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Chromenonyl-1,4-dihydropyridines and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2638555